GHK-Cu is a small copper-binding tripeptide (340 Daltons) discovered by Loren Pickart in 1973
Anat Rec 231(4):482497
It promotes the movement of endothelial cells (blood vessel lining), keratinocytes (skin cells), and other cell types involved in healing
Studies have shown that GLP-1 RA users often do not eat adequate amounts of protein and have insufficient intake of multiple key nutrients
It neutralizes reactive oxygen species triggered by UV radiation, pollution, and metabolic byproducts all of which accelerate collagen breakdown, fine lines, and a dull appearance
In vitro data suggest that the primary route of metabolism of empagliflozin in humans is glucuronidation by the uridine 5'-diphospho-glucuronosyltransferases UGT1A3, UGT1A8, UGT1A9, and UGT2B7